This inventor holds 1 USPTO granted patent. Top assignee: Adir Et Compagnie. Active years: 1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1993
Title: Yvette Morot-Gaudry: Innovator in Cholinergic Transmission Disorders
Introduction
Yvette Morot-Gaudry is a notable inventor based in Gif sur Yvette, France. She has made significant contributions to the field of medicinal chemistry, particularly in the treatment of cholinergic transmission disorders. Her innovative work has led to the development of a unique compound that holds promise for therapeutic applications.
Latest Patents
Yvette Morot-Gaudry holds a patent for the "Use of N-(1-hexahydroazepinylalkyl) acetamides for the treatment of cholinergic transmission disorders." This invention relates to the use of a compound selected from those of a specific formula, which is designed to address various disorders associated with cholinergic transmission.
Career Highlights
Throughout her career, Yvette has demonstrated a strong commitment to research and innovation. She is currently associated with Adir Et Compagnie, where she continues to explore new avenues in medicinal chemistry. Her work has been instrumental in advancing the understanding of cholinergic mechanisms and their implications in health.
Collaborations
Yvette has collaborated with esteemed colleagues such as Maurice Israel and Max Robba. These partnerships have enriched her research and contributed to the development of her patented inventions.
Conclusion
Yvette Morot-Gaudry's contributions to the field of medicinal chemistry are noteworthy. Her innovative patent for treating cholinergic transmission disorders showcases her dedication to improving health outcomes through scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile